Datar Cancer Genetics Unveils Next Generation Multi-Analyte, AI-Powered Decision Support Platform for Personalized Treatment of Difficult-to-Treat Cancers.

LONDON, MUNICH and NEW DELHI, Feb. 3, 2025 /PRNewswire/ — Datar Cancer Genetics (DCG) has launched Exacta AI, a next generation multi-analyte AI-driven platform providing optimized treatment options for cancer patients who have exhausted the standard options. It integrates a 360° tumor…